SAMAALB
LIVE

Serial Number

79241267

Owner

NOVARTIS AG

Filing Date

Jul 29, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SAMAALB Trademark

Serial Number: 79241267 • Registration: 5663867

SAMAALB is a trademark filed by NOVARTIS AG on July 29, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

July 29, 2018

Registration Date

January 29, 2019

Published for Opposition

November 13, 2018

Cancellation Date

October 2, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Oct 23, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 23, 2023 DETH
NOTIFICATION PROCESSED BY IB
Jul 26, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 13, 2019 FICS
FINAL DISPOSITION PROCESSED
Mar 13, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 28, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 29, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Nov 30, 2018 GPNX
PUBLISHED FOR OPPOSITION
Nov 13, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 7, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 7, 2018 OP2R
NOTICE OF PUBLICATION
Oct 24, 2018 NPUB
APPLICATION FILING RECEIPT MAILED
Oct 2, 2018 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2018 CNSA
ASSIGNED TO EXAMINER
Sep 28, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 25, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 20, 2018 SDRC